Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{206342,
        author = {A.NARASIMHAREDDY and G.NAGAPRAVEEN and D.SANJANA and SK.SANJUDA},
        title = {ARTIFICIAL INTELLIGENCE-BASED MEDICAL DEVICE TECHNOLOGIES IMPLEMENTATION STRATEGIES IN INDIAN HEALTH CARE INDUSTRY},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {13},
        number = {2},
        pages = {1112-1120},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=206342},
        abstract = {Artificial intelligence (AI) is transforming the healthcare sector by enhancing disease diagnosis, improving treatment planning, accelerating drug discovery, and optimizing clinical decision-making. The integration of AI technologies, including machine learning, deep learning, natural language processing, and computer vision, has led to the development of intelligent medical devices and Software as a Medical Device (SaMD), enabling more accurate, efficient, and personalized healthcare services. AI-powered applications such as clinical decision support systems, medical imaging, remote patient monitoring, robotic-assisted surgery, electronic health records, and virtual health assistants have significantly improved healthcare delivery while reducing operational costs and human error.
Despite these advancements, the widespread adoption of AI in healthcare presents several regulatory, ethical, legal, and technical challenges, including data privacy, algorithmic bias, cybersecurity, transparency, accountability, and clinical validation. Regulatory agencies worldwide, including the U.S. Food and Drug Administration (FDA), the Medicines and Healthcare products Regulatory Agency (MHRA), the International Medical Device Regulators Forum (IMDRF), and India's Central Drugs Standard Control Organization (CDSCO), are developing frameworks to ensure the safety, effectiveness, and quality of AI-enabled medical devices. In India, initiatives such as the Ayushman Bharat Digital Mission (ABDM), the Digital Personal Data Protection Act, 2023, and evolving medical device regulations are supporting the responsible integration of AI into healthcare.
This review summarizes the current applications of AI in healthcare, examines AI-enabled medical devices and their regulatory landscape, discusses major implementation challenges and ethical considerations, and highlights future directions for AI-driven healthcare systems. Continued collaboration among healthcare professionals, researchers, policymakers, regulatory authorities, and technology developers will be essential to establish trustworthy, transparent, and patient-centric AI solutions. With appropriate regulatory oversight, robust digital infrastructure, and responsible innovation, artificial intelligence has the potential to revolutionize global healthcare by improving patient outcomes, increasing healthcare accessibility, and promoting precision medicine.},
        keywords = {Artificial Intelligence, Healthcare, Software as a Medical Device (SaMD), Machine Learning, Deep Learning, Medical Devices, Clinical Decision Support, Digital Health, Healthcare Regulation, Personalized Medicine, India.},
        month = {July},
        }